Oncolytics Biotech Dirección
Dirección controles de criterios 3/4
El CEO de Oncolytics Biotech es Wayne Pisano, nombrado en Jun 2024, tiene una permanencia de menos de un año. posee directamente un 0.25% de las acciones de la empresa, con un valor de CA$309.60K. La antigüedad media del equipo directivo y de la junta directiva es de 2.9 años y 5.5 años, respectivamente.
Información clave
Wayne Pisano
Chief Executive Officer (CEO)
CA$165.0k
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | less than a year |
Participación del CEO | 0.2% |
Permanencia media de la dirección | 2.9yrs |
Promedio de permanencia en la Junta Directiva | 5.5yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Feb 23Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Nov 10We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Jul 07Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Mar 24Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?
Dec 09We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate
Aug 25Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
May 12We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Dec 02We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Aug 05Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth
Apr 15We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Dec 31CEO
Wayne Pisano (69 yo)
less than a year
Permanencia
CA$165,010
Compensación
Mr. Wayne F. Pisano, MBA, is Interim Chief Executive Officer at Oncolytics Biotech Inc. since June 24, 2024. He has been an Independent Director of Altimmune, Inc. since August 30, 2018. Mr. Pisano had bee...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Interim CEO & Chairman of the Board | less than a year | CA$165.01k | 0.25% CA$ 309.6k | |
Chief Financial Officer | 12yrs | CA$1.32m | 1.16% CA$ 1.5m | |
President | less than a year | CA$2.25m | 0.12% CA$ 157.0k | |
Chief Medical Officer | 2.9yrs | CA$1.36m | 0.67% CA$ 841.4k | |
Vice President of Product Development | 6.1yrs | CA$727.64k | 0.67% CA$ 842.3k | |
Vice President of Clinical Operations | 1.8yrs | CA$683.55k | sin datos | |
Director of Investor Relations & Communication | no data | sin datos | sin datos | |
Consultant | 5.5yrs | CA$25.98k | sin datos |
2.9yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de ONC se considera experimentado (2.9 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Interim CEO & Chairman of the Board | 11.5yrs | CA$165.01k | 0.25% CA$ 309.6k | |
Independent Director | 9.4yrs | CA$123.96k | 0.49% CA$ 619.6k | |
Independent Director | 2.4yrs | CA$116.36k | sin datos | |
Independent Director | 2.3yrs | CA$107.40k | 0.41% CA$ 513.2k | |
Independent Director | less than a year | sin datos | sin datos | |
Independent Director | 10.4yrs | CA$130.58k | 0.17% CA$ 207.4k | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
Independent Director | 7yrs | CA$124.95k | 0.064% CA$ 79.8k | |
Member of Scientific Advisory Board | 7yrs | sin datos | sin datos | |
Member of Scientific Advisory Board | 4.1yrs | sin datos | sin datos |
5.5yrs
Permanencia media
68yo
Promedio de edad
Junta con experiencia: La junta directiva de ONC se considera experimentada (5.5 años de antigüedad promedio).